John Dessauer’s Outlook

John Dessauer’s Outlook is the new, web-enabled version of my monthly global investment newsletter – previously called John Dessauer’s Investor’s World. After almost 30 years of publishing my investment research and stock market commentary, I am excited to be utilizing power...
Read More

GlaxoSmithKline (GSK)

Recent events have put this drug maker in an undervalued state. The shares have a current dividend yield of 4.7%, paid quarterly. GlaxoSmithKline (GSK) from John Dessauer’s Outlook GlaxoSmithKline (GSK) reported a disappointing second quarter and said there is another corruption investigation, this time in Syria. stock...
Read More